Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: equine encephalitis virus vaccine - Maxygen

Next Previous
Drug Profile

Research programme: equine encephalitis virus vaccine - Maxygen

Alternative Names: Eastern equine encephalitis virus vaccine - Maxygen; Maxy 829; Maxy-EE; Vaccines against encephalitis alphaviruses - Maxygen; Venezuelan equine encephalitis virus vaccine - Maxygen; Western equine encephalitis virus vaccine - Maxygen

Latest Information Update: 02 Apr 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Maxygen
  • Developer Maxygen; United States Army Medical Research Institute of Infectious Diseases
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Eastern equine encephalomyelitis; Venezuelan equine encephalomyelitis; Western equine encephalitis virus infections

Most Recent Events

  • 10 Jun 2013 Discontinued - Preclinical for Encephalitis virus infections in USA (Parenteral)
  • 18 Sep 2008 Preclinical development is ongoing
  • 18 Sep 2008 This equine encephalitis vaccine programme is available for licensing (http://www.maxygen.com)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top